Cellular and Molecular Basis of Sleep Loss Neural Injury in Alzheimer Disease

阿尔茨海默病睡眠缺失神经损伤的细胞和分子基础

基本信息

  • 批准号:
    10586062
  • 负责人:
  • 金额:
    $ 73.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-15 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

ABSTRACT Chronic short sleep (CSS) is common in developed countries and yet is likely to be a key modifier of Alzheimer disease (AD), the most prevalent tauopathy in older adults. Sleep loss acutely increases tau in humans and in mice, and we have recently shown that CSS hastens the temporal progression of tauopathy in the P301S murine model of tauopathy, increasing all aspects of tauopathy, including soluble tau oligomers, pathologic tau aggregation, gliosis, neuron loss and neurobehavioral impairment. The fact that all aspects of tauopathy are impacted by sleep loss leads us to hypothesize that CSS targets a key upstream initiating factor. Hippocampal calcium/calmodulin dependent kinase II (HC CAMKII) neurons are among some of the most vulnerable neurons in AD and show early tau accumulation. We find that CSS massively increases calcium transients in HC CAMKII neurons, activates CAMKII and calpain, and induces uncompensated endoplasmic reticulum stress with loss of molecular chaperone BiP. Our overall hypothesis is that CSS results in excessive intracellular calcium bursts in HC CAMKII neurons, leading to sustained CAMKII and calpain activation, pathogenic tau modifications, and chronic uncompensated endoplasmic reticulum stress with loss of BiP that feeds back positively to perpetuate injury. Here we propose to critically test the role of each component of our working model in the biochemical, pathological and behavioral aspects of tauopathy and CSS-hastening of tauopathy in the P301S model. In Aim 1, we will test the role of CSS-increased calcium and calpain in HC CAMKII neurons in the CSS HC tau changes by genetically suppressing local HC CAMKII calcium and calpain, while verifying suppressed calcium transients with in vivo calcium imaging of CAMKII neurons. In Aim 2, using pharmacologic inhibition and conditional HC transgenic knock down of CAMKII across CSS, we will determine to what role CAMKII induces CSS-induced HC ER stress and CSS effects on tauopathy, and in Aim 3, we will critically test the role of CSS-reduced BiP in the temporal progression of tauopathy and CSS effects on tauopathy. Collectively, the proposed studies will identify important in vivo mechanisms by which CSS hastens the temporal progression of tauopathy and will substantiate therapeutic avenues to lessen CSS exacerbation of tauopathy and tauopathy progression in general.
摘要 慢性短睡眠(CSS)在发达国家很常见,但很可能是 阿尔茨海默病(AD),老年人中最常见的肌萎缩症。睡眠不足会显著增加tau 在人类和小鼠身上,我们最近表明,css加速了 顺势疗法在P301S小鼠模型中的顺势疗法,增加了顺势疗法的方方面面,包括可溶性 Tau寡聚体、病理性tau聚集、胶质细胞增厚、神经元丢失和神经行为障碍。事实是 紧张症的所有方面都会受到睡眠不足的影响,这让我们假设CS针对的是一个关键的 上游启动因素。海马钙/钙调蛋白依赖性激酶II(HC CaMKII)神经元 是阿尔茨海默病中最脆弱的神经元之一,并显示出早期tau的积累。我们发现 CS显著增加了HC CaMKII神经元的钙瞬变,激活了CaMKII和钙蛋白酶,并 诱导失代偿的内质网应激,分子伴侣Bip的丢失。我们的整体 假设是CS导致HC CaMKII神经元细胞内过度钙爆发,导致 持续的CaMKII和Calain激活,致病性tau修饰,以及慢性失代偿 内质网应激与BiP的丢失正反馈使损伤永久化。在这里我们 建议批判性地测试我们工作模型中每个组件在生化、病理 以及在P301S模型中伸展疗法的行为方面和伸展疗法的加速效应。在目标1中,我们 将测试css增加的钙和钙蛋白对HC CaMKII神经元在css中HC tau变化的作用 通过遗传抑制局部HC CaMKII钙和钙蛋白,同时验证被抑制的钙 CaMKII神经元的体内钙成像的瞬变。在目标2中,使用药物抑制和 有条件的HC转基因在整个CS中击倒CaMKII,我们将确定CaMKII扮演什么角色 诱导css诱导的HC ER应激和css对紧张症的影响,在目标3中,我们将严格测试 Css减少的Bip在直立性肌病的时间进展中的作用以及css对直立性肌病的影响。 总而言之,拟议的研究将确定重要的体内机制,通过这些机制,CSS加速了 肌萎缩侧索硬化症的时间进展,并将证实减轻CS恶化的治疗途径 直立性和直立性进展的一般情况。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NIRMALA NIRINJINI NAIDOO其他文献

NIRMALA NIRINJINI NAIDOO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NIRMALA NIRINJINI NAIDOO', 18)}}的其他基金

Restoration of proteostasis to address co-occurring conditions in Down Syndrome
恢复蛋白质稳态以解决唐氏综合症的并发病症
  • 批准号:
    10518555
  • 财政年份:
    2022
  • 资助金额:
    $ 73.12万
  • 项目类别:
Interactions between the immune response and lipid homeostasis in regulating sleep during sickness
免疫反应与脂质稳态之间的相互作用在调节疾病期间的睡眠中
  • 批准号:
    10634707
  • 财政年份:
    2022
  • 资助金额:
    $ 73.12万
  • 项目类别:
Cellular and Molecular Basis of Sleep Loss Neural Injury in Alzheimer Disease
阿尔茨海默病睡眠缺失神经损伤的细胞和分子基础
  • 批准号:
    10373983
  • 财政年份:
    2020
  • 资助金额:
    $ 73.12万
  • 项目类别:
Mechanisms of Cellular Stress-Induced Sleep
细胞压力诱发睡眠的机制
  • 批准号:
    9175443
  • 财政年份:
    2016
  • 资助金额:
    $ 73.12万
  • 项目类别:
Mechanisms of Cellular Stress-Induced Sleep
细胞压力诱发睡眠的机制
  • 批准号:
    9356563
  • 财政年份:
    2016
  • 资助金额:
    $ 73.12万
  • 项目类别:
Age Impaired ER Homeostasis in Wake-Active Neurons: BiP/Nox2 Crosstalk
唤醒活跃神经元中年龄受损的内质网稳态:BiP/Nox2 串扰
  • 批准号:
    7906549
  • 财政年份:
    2009
  • 资助金额:
    $ 73.12万
  • 项目类别:
Biomarker for Sleep Loss: A Proteomic Determination
睡眠不足的生物标志物:蛋白质组学测定
  • 批准号:
    7935427
  • 财政年份:
    2009
  • 资助金额:
    $ 73.12万
  • 项目类别:
Biomarker for Sleep Loss: A Proteomic Determination
睡眠不足的生物标志物:蛋白质组学测定
  • 批准号:
    7816516
  • 财政年份:
    2009
  • 资助金额:
    $ 73.12万
  • 项目类别:
Age Impaired ER Homeostasis in Wake-Active Neurons: BiP/Nox2 Crosstalk
唤醒活跃神经元中年龄受损的内质网稳态:BiP/Nox2 串扰
  • 批准号:
    7673713
  • 财政年份:
    2008
  • 资助金额:
    $ 73.12万
  • 项目类别:
Age Impaired ER Homeostasis in Wake-Active Neurons: BiP/Nox2 Crosstalk
唤醒活跃神经元中年龄受损的内质网稳态:BiP/Nox2 串扰
  • 批准号:
    7513243
  • 财政年份:
    2008
  • 资助金额:
    $ 73.12万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 73.12万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 73.12万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 73.12万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 73.12万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 73.12万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 73.12万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 73.12万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 73.12万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 73.12万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 73.12万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了